Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|29|4513-4517

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4513-4517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 276-296

Bentham Science Publishers

Access to resources Recommend Favorite

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

Multiple Roles of Histamine in Autoimmune Demyelinating Disease of the Central Nervous System

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 6, 2011-12 ,pp. : 418-426

Bentham Science Publishers

Access to resources Recommend Favorite

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 667-675

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine in Immune Regulation: Possible Roles in Autoimmune Demyelinating Disease of the Central Nervous System

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 6, 2005-12 ,pp. : 637-643

Bentham Science Publishers

Access to resources Recommend Favorite